Quartesian Surpasses 250 Studies Employing Medrio's EDC Platform
Quartesian Surpasses 250 Studies Employing Medrios EDC Platform News provided by Share this article Share this article PRINCETON, N.J., May 4, 2021 /PRNewswire/ -- Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, announced today that they have deployed Medrios cloud-based EDC platform for 265 clinical studies world-wide. Quartesians partnership with Medrio began in 2009 and they were an early participant in the Medrio...
Stephen Boccardo Prnewswire Quartesian Nicole Latimer Vp Business Development Medrio Partner Program Clinical Research Organization
Source: prnewswire.com